Sopheon has been notified that certain directors of the Company have undertaken share transfers details of which are given below.
Barry Mence has transferred 3,000 ordinary shares of 20 pence each in the capital of the Company (“Ordinary Shares”) to be held through his self-invested personal pension (“SIPP”). Barry Mence has also transferred 8,500 Ordinary Shares to his wife Maria Mence, and she has then transferred 3,000 Ordinary Shares to be held through her individual savings account (“ISA”). Barry Mence’s total beneficial interest in Ordinary Shares, including those held by his wife, remains unchanged at 1,447,576 Ordinary Shares.
Stuart Silcock has held a non-beneficial interest in 4,000 Ordinary Shares held in trust for his adult children, these have now been transferred into their own names.
Stuart Silcock’s SIPP has bought 11,000 Ordinary Shares held in his own name as Bare Trustee for his grandchildren. In addition, he has transferred 8,500 Ordinary Shares to his wife, Christine Silcock and she has then transferred 2,800 Ordinary Shares to be held through her ISA. As a result, Stuart Silcock’s total beneficial interest in Ordinary Shares including those of his wife, as well as his interest in Ordinary Shares held in Bare Trust for his grandchildren, remains unchanged at 274,627 Ordinary Shares.
Arif Karimjee has transferred 17,500 Ordinary Shares held in his own name to his brokerage account. He has then transferred 1,500 Ordinary Shares to be held through his ISA, and 1,500 Ordinary Shares to be held through his SIPP. His total beneficial interest in Ordinary Shares remains unchanged at 50,000 Ordinary Shares.
For Further Information Contact:
| Barry Mence, Chairman Arif Karimjee, CFO |
Sopheon plc | + 44 (0) 1276 919 560 |
| Carl Holmes / Giles Rolls (corporate finance) Mia Gardener (corporate broking) |
finnCap | + 44 (0) 20 7220 0500 |
About Sopheon
Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange.
The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.